Skip to main content
S&P 5007,777.81-0.31%DOW51,139.39-0.08%NASDAQ27,363.03-0.64%BTC$82,054.00-1.43%ETH$2,517.69-2.08%GOLD$4,150.30+0.23%OIL$92.21+4.45%
Smart Investors Daily
SID Premium
TM

NASDAQ · TMDX

TransMedics Group, Inc.

Healthcare · Medical - Devices

$81.07

Down-$2.14 (-2.64%)

Updated Oct 8, 2026, 1:54 PM

SID Score

4.3/10

Composite research score

Smart Money

58/100

Neutral

Market cap
4.37B
P/E ratio
47.56
Dividend yield
0.00%
52-week range
$60.11 – $135.28
Volume
962.66K
Avg. volume
933.82K

Price performance · TMDX

TMDX price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 7, 2026

TMDX closed at $81.07 after 21 trading sessions, down 6.17% for the selected period.

Last close
$81.07
Period change
-6.17%
Period low
$78.64
Period high
$88.09
Daily close
View OHLC price history
TMDX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 7, 2026$80.96$83.90$80.56$81.07962.66K
Oct 6, 2026$83.87$84.05$80.08$80.28570.85K
Oct 5, 2026$79.50$83.40$77.3706$82.99995.11K
Oct 2, 2026$79.81$80.85$77.14$79.7951.22M
Oct 1, 2026$83.92$84.24$78.02$78.64880.64K
Sep 30, 2026$84.87$84.87$81.55$83.45566.81K
Sep 29, 2026$82.56$84.218$81.755$84.07440.2K
Sep 28, 2026$86.38$86.38$82.70$82.73422.56K
Sep 25, 2026$83.50$85.6925$81.80$85.29696.74K
Sep 24, 2026$86.09$86.09$82.5329$83.90623.71K
Sep 23, 2026$88.22$89.19$85.07$87.00615.6K
Sep 22, 2026$88.15$89.80$86.5001$88.07750.86K
Sep 21, 2026$87.35$89.53$86.745$87.29591.04K
Sep 18, 2026$87.18$87.98$85.01$86.421.44M
Sep 17, 2026$88.00$89.41$85.465$86.66690.58K
Sep 16, 2026$88.17$88.28$86.29$87.56464.75K
Sep 15, 2026$86.39$90.67$85.4703$88.09942.86K
Sep 14, 2026$82.615$88.49$80.585$85.86943.38K
Sep 11, 2026$85.36$86.00$79.23$82.181.25M
Sep 10, 2026$85.27$87.55$83.69$85.04591.86K
Sep 9, 2026$87.47$87.71$84.87$86.40665.16K

Latest TMDX news

The latest Smart Investors Daily articles mentioning TMDX.

Stock researchCompany · Overview

TMDX research

Overview

Company profile and research snapshot.

Company profile

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$148.00
Implied upside
—
Analysts
20
TMDX recent ratings
DateFirmRatingTarget
Oct 7, 2026BarclaysOverweight—
Sep 8, 2026TD CowenBuy—
Aug 5, 2026Piper SandlerOverweight—
Aug 5, 2026UBSNeutral—
Aug 3, 2026NeedhamBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 2, 2026

TransMedics Group (TMDX) Stock Looks Below Fair Value On Earnings

TransMedics Group has seen its share price slide in recent months after a strong multi‑year run, which raises an obvious question for you as an investor. Is the current US$78.64 price still aligned with what the company is earning today, or has sentiment moved ahead of the underlying profit story? Over the past 5 years the stock has gained about 157.4%, which puts real weight on whether the earnings profile can support where the valuation now sits. The business relies on turning highly...

Yahoo · Oct 2, 2026

TransMedics Group (TMDX) Could Be 19% Undervalued If Its Growth Narrative Holds

TransMedics Group (TMDX) has drawn investor attention after recent trading left the stock around $78.64, with returns down over the past month but higher over the past three months and three years. Short term momentum for TransMedics Group has faded, with the share price return down 5.76% over one day, 6.27% over the past week and 4.38% over the past month. At the same time, a 14.20% 90 day share price return and a 54.08% three year total shareholder return point to a stock where sentiment...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By